Breaking Finance News

BREAKING- Opexa Therapeutics Spikes Higher (OPXA)

Whoever said that Seeking Alpha doesn’t move stocks hasn’t been watching very closely. It’s becoming as much of a market mover as CNBC or other financial media outlets.

Opexa Pharmaceuticals (NASDAQ: OPXA) spiked nearly 1 percent after a Seeking Alpha article was published called, 9 Compelling Reasons To Buy Opexa Therapeutics Right Now

Among the arguments:

Opexa just completed an $18 million capital raise, bolstering the company’s balance sheet with a solid cash buffer that should be welcomed by investors. Combined with the existing cash on its balance sheet, Opexa is currently trading just barely above its net cash. Investors are effectively paying nothing for the business at current levels; a virtually free option on a potentially game-changing MS drug as well as other possible indications.

[stock-tools exchange="NASDAQ" symbol="OPXA" image_height="230" image_width="350"]

Disclosure: At the time of this writing, the author had no position in the company mentioned.

New to Breaking Finance News? Read about our format here.

 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.